Keyword

entrectinib

Description: A targeted anticancer drug that inhibits TRK, ROS1, and ALK tyrosine kinases in tumors with relevant molecular alterations.
Wikidata ID: wiki/Q25323953
OpenAlex ID: keywords/entrectinib
2018 · Emiliano Cocco, Maurizio Scaltriti, et al. · Nature Reviews Clinical Oncology · 1,559
2019 · Alexander Drilon, Salvatore Siena, et al. · The Lancet Oncology · 565
2019 · Christopher Nevala-Plagemann, Manuel Hidalgo, et al. · Nature Reviews Clinical Oncology · 420
2020 · Davendra P.S. Sohal, Erin B. Kennedy, et al. · Journal of Clinical Oncology · 335
2016 · Elena Ardini, Maria Menichincheri, et al. · Molecular Cancer Therapeutics · 335
2015 · Mariangela Russo, Sandra Misale, et al. · Cancer Discovery · 322
2019 · A. Drilon · Annals of Oncology · 303
2017 · Yekaterina B. Khotskaya, Vijaykumar R. Holla, et al. · Pharmacology & Therapeutics · 301
2015 · Andrea Sartore-Bianchi, Elena Ardini, et al. · JNCI Journal of the National Cancer Institute · 250
2022 · George D. Demetri, Filippo De Braud, et al. · Clinical Cancer Research · 247
2015 · Anna F. Farago, Long P. Le, et al. · Journal of Thoracic Oncology · 231
2021 · C. B. Westphalen, M. G. Krebs, et al. · npj Precision Oncology · 215
2019 · Zaina T. Al-Salama, Susan J. Keam · Drugs · 182
2018 · Ed S. Kheder, David S. Hong · Clinical Cancer Research · 165
2022 · Lillian R. Klug, Homma M. Khosroyani, et al. · Nature Reviews Clinical Oncology · 156
2015 · Christian Rolfo, Rossana Ruiz, et al. · Expert Opinion on Investigational Drugs · 153
2020 · Leigh Marcus, Martha Donoghue, et al. · Clinical Cancer Research · 151
Works count: 1,158
Citation count: 19,570
Year
Topic
Type